Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC
Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Optimizing ROS1 Inhibitor Therapy in NSCLC
Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPH, Rohit Gosain, MD, Rahul Gosain, MD, MBA

How to Manage Anti-EGFR Toxicities in NSCLC
How to Manage Anti-EGFR Toxicities in NSCLC

Gilberto Lopes, MD